Miller C - Search Results

1

Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality.

Papanicolaou GA, Meyers BR, Meyers J, Mendelson MH, Lou W, Emre S, Sheiner P, Miller C. Papanicolaou GA, et al. Among authors: miller c. Clin Infect Dis. 1996 Oct;23(4):760-6. doi: 10.1093/clinids/23.4.760. Clin Infect Dis. 1996. PMID: 8909841

2

Tuberculosis in liver transplant patients.

Meyers BR, Halpern M, Sheiner P, Mendelson MH, Neibart E, Miller C. Meyers BR, et al. Among authors: miller c. Transplantation. 1994 Aug 15;58(3):301-6. Transplantation. 1994. PMID: 8053051

3

Infectious ocular complications in orthotopic liver transplant patients.

Papanicolaou GA, Meyers BR, Fuchs WS, Guillory SL, Mendelson MH, Sheiner P, Emre S, Miller C. Papanicolaou GA, et al. Among authors: miller c. Clin Infect Dis. 1997 Jun;24(6):1172-7. doi: 10.1086/513655. Clin Infect Dis. 1997. PMID: 9195078

4

Reversal of gastrointestinal toxicity associated with long-term FK506 immunosuppression by conversion to cyclosporine in liver transplant recipients.

Mor E, Schwersenz A, Sheiner PA, Emre S, Schwartz ME, Miller CM. Mor E, et al. Among authors: miller cm. Transplantation. 1994 Apr 15;57(7):1130-2. Transplantation. 1994. PMID: 7513098 No abstract available.

5

Acute renal failure associated with the use of ibuprofen in two liver transplant recipients on FK506.

Sheiner PA, Mor E, Chodoff L, Glabman S, Emre S, Schwartz ME, Miller CM. Sheiner PA, et al. Among authors: miller cm. Transplantation. 1994 Apr 15;57(7):1132-3. Transplantation. 1994. PMID: 7513099 No abstract available.

6

Serum lipid changes in liver transplant recipients in a prospective trial of cyclosporine versus FK506.

Jindal RM, Popescu I, Emre S, Schwartz ME, Boccagni P, Meneses P, Mor E, Sheiner P, Miller CM. Jindal RM, et al. Among authors: miller cm. Transplantation. 1994 May 15;57(9):1395-8. doi: 10.1097/00007890-199405150-00020. Transplantation. 1994. PMID: 7514317 Clinical Trial. No abstract available.

7

Diabetogenicity of FK506 versus cyclosporine in liver transplant recipients.

Jindal RM, Popescu I, Schwartz ME, Emre S, Boccagni P, Miller CM. Jindal RM, et al. Among authors: miller cm. Transplantation. 1994 Aug 15;58(3):370-2. Transplantation. 1994. PMID: 7519799 Clinical Trial. No abstract available.

8

Successful use of an enhanced immunosuppressive protocol with plasmapheresis for ABO-incompatible mismatched grafts in liver transplant recipients.

Mor E, Skerrett D, Manzarbeitia C, Sheiner PA, Schwartz ME, Emre S, Thung SN, Miller CM. Mor E, et al. Among authors: miller cm. Transplantation. 1995 Apr 15;59(7):986-90. doi: 10.1097/00007890-199504150-00011. Transplantation. 1995. PMID: 7709460

9

High-dose acyclovir and intravenous immune globulin reduce the incidence of CMV disease after liver transplantation.

Mor E, Meyers BR, Yagmur O, Kishikawa K, Sheiner PA, Emre S, Schwartz ME, Miller CM. Mor E, et al. Among authors: miller cm. Transpl Int. 1995;8(2):152-6. doi: 10.1007/BF00344426. Transpl Int. 1995. PMID: 7766298

10

Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation.

Sheiner PA, Schwartz ME, Mor E, Schluger LK, Theise N, Kishikawa K, Kolesnikov V, Bodenheimer H, Emre S, Miller CM. Sheiner PA, et al. Among authors: miller cm. Hepatology. 1995 Jan;21(1):30-4. Hepatology. 1995. PMID: 7806166

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,709 results

Search Page

Filters